Tactile Medical completed the acquisition of LymphaTech for $6.8m.

Tactile Medical, a medical technology company providing therapies for people with chronic disorders, completed the acquisition of LymphaTech, a healthcare technology company focused on 3D measurement solutions, for $6.8m. “This acquisition is a milestone in Tactile’s evolution from a product-based company to a comprehensive, integrated solutions leader for lymphatic dysfunction. By bringing together Tactile and LymphaTech, we become uniquely positioned to support patients and clinicians from early disease intervention to innovative connected therapies with long-term support and monitoring alongside our Kylee™ patient engagement application," Sheri Dodd, Tactile Medical CEO.